100
Participants
Start Date
November 1, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Toripalimab
PD-1 inhibitor
IMRT to the nasopharynx and neck
IMRT to the nasopharynx and neck
Gemcitabine and Cisplatin Chemotherapy
Systemic chemotherapy
Adjuvant chemotherapy with Capecitabine
Adjuvant chemotherapy after radiation
Xiaomin Ou, Shanghai
Fudan University Eye and ENT Hospital
UNKNOWN
Anhui Provincial Hospital
OTHER_GOV
Sir Run Run Shaw Hospital
OTHER
Hangzhou Cancer Hospital
OTHER
Ningbo Medical Center Lihuili Hospital
OTHER_GOV
The First People's Hospital of Changzhou
OTHER
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
OTHER
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
OTHER
Nanfang Hospital, Southern Medical University
OTHER
Shenzhen People's Hospital
OTHER
First Affiliated Hospital of Xi'anJiaotong Univerisity
UNKNOWN
Guangzhou Panyu Central Hospital
OTHER
Fujian Cancer Hospital
OTHER_GOV
Fudan University
OTHER